These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2936157)

  • 1. Can endogenous prostacyclin contribute to the antithrombotic effect of low dose aspirin in vivo?
    Weselcouch EO; Humphrey WR; Aiken JW
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():513-6. PubMed ID: 2936157
    [No Abstract]   [Full Text] [Related]  

  • 2. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.
    Moncada S; Korbut R
    Lancet; 1978 Jun; 1(8077):1286-9. PubMed ID: 78050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
    Moncada S
    Mater Med Pol; 1980; 12(3):207-12. PubMed ID: 7019591
    [No Abstract]   [Full Text] [Related]  

  • 5. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor.
    Murata T; Ushikubi F; Matsuoka T; Hirata M; Yamasaki A; Sugimoto Y; Ichikawa A; Aze Y; Tanaka T; Yoshida N; Ueno A; Oh-ishi S; Narumiya S
    Nature; 1997 Aug; 388(6643):678-82. PubMed ID: 9262402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin dosage and antithrombotic effect.
    Clagett GP; Russo M; Hufnagel H; Collins GJ; Rich NM
    Surg Forum; 1979; 30():199-201. PubMed ID: 538593
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostaglandin I2 (prostacyclin).
    Kelton JG; Blajchman MA
    Can Med Assoc J; 1980 Jan; 122(2):175-9. PubMed ID: 6988063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation.
    Borgdorff P; Tangelder GJ; Paulus WJ
    J Am Coll Cardiol; 2006 Aug; 48(4):817-23. PubMed ID: 16904555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosis.
    Witt W; Müller B
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():279-84. PubMed ID: 2444077
    [No Abstract]   [Full Text] [Related]  

  • 13. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo.
    Bullough DA; Zhang C; Montag A; Mullane KM; Young MA
    J Clin Invest; 1994 Oct; 94(4):1524-32. PubMed ID: 7929829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent low dose platelet inhibitory effects of clopidogrel and aspirin on coronary thrombus formation in an animal model of acute unstable angina.
    Bierbach B; Horstick G; Berg O; Heimann A; Münzel T; Vahl CF; Kempski O; Darius H
    Thromb Haemost; 2006 Feb; 95(2):354-61. PubMed ID: 16502561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PD0348292, a selective factor Xa inhibitor, to antiplatelet agents for the inhibition of arterial thrombosis.
    Karnicki K; Leadley RJ; Baxi S; Peterson T; Wysokinski W; McBane RD
    Thromb Haemost; 2008 Apr; 99(4):759-66. PubMed ID: 18392334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced platelet accumulation onto injured carotid arteries in rabbits after aspirin treatment.
    Buchanan MR; Dejana E; Gent M; Mustard JF; Hirsch J
    J Clin Invest; 1981 Feb; 67(2):503-8. PubMed ID: 7007438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.
    Aiken JW; Shebuski RJ; Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1981 Nov; 219(2):299-308. PubMed ID: 6270303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.